Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-metal hip implants effective August 31, citing slowing sales and new FDA classification.
Johnson & Johnson (NYSE:JNJ) is pulling the plug on its troubled metal-on-metal hip implant business, effective August 31.
Globus Medical accuses Johnson & Johnson's DePuy Synthes unit of violating its patent for an intervertebral fusion implant with the Zero-P VA device.
Matthew Scott, former director of operations for Zimmer Holdings' dental business, is named senior vice president of operations for custom knee implant maker ConforMIS.
ConforMIS lured Zimmer's dental business operations director, Matthew Scott, away to be its new chief operating officer as it looks to scale up its customized knee implant business.
The Bedford, Mass.-based medical device company said Scott bring's a decade's worth of ops experience from his tenure at Zimmer. ConforMIS makes knee replacement implants and instrumentation that are custom-fit to patients' morphology.
NuVasive said it paid $4.5 million to acquire ANC LLC, a contract manufacturer in Ohio that makes some of its spinal implants.
NuVasive Inc. (NSDQ:NUVA) said it paid $4.5 million to buy 1 of its contract manufacturing partners, ANC LLC, based in Fairmont, Ohio.
The San Diego-based medical device company said ANC, a partner since 2010, is "1 of NuVasive's significant implant suppliers."
A bellwether lawsuit representing wide-scale complaints against Johnson & Johnson subsidiary DePuy Orthopaedics is rescheduled, now slated to begin in June.
The 1st trial representing a multi-district complaint against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics was delayed by court order, now slated to begin in June.
A Chicago jury leaned in Johnson & Johnson's favor this week in finding that the company was not liable for the alleged injuries experienced by a patient implanted with a metal-on-metal ASR XL hip implant.
A Chicago jury this week jury ruled in favor of healthcare giant Johnson & Johnson (NYSE:JNJ), rejecting a patient's claims that the company was liable for injuries she allegedly sustained after receiving the metal-on-metal ASR XL hip implant.
A coalition of 4 large U.S. healthcare groups teams up to launch independent studies assessing the long-term effectiveness of medical implants.
A quartet of U.S. healthcare groups are teaming up to take a closer look at the long-term effectiveness of medical implants, launching independent clinical studies in order to evaluate devices and their outcomes for patients, the group announced this week.